Pfizer has announced the release of an antibiotic used to treat infections caused by resistant bacteria. The antibiotic, Zavicefta, is a combination of avibactam and ceftazidime and will be used for gram-negative infections, in which a rise in resistant bacteria has been traced. Clinical trials have concluded that the new drug is just effective in treating the rare, super-resistant infections. Read the full article here.